iPS Academia Japan

NEW YORK (GenomeWeb News) – Life Technologies today announced a worldwide, non-exclusive deal with iPS Academia Japan for its induced pluripotent stem cell patent portfolio.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has licensed worldwide rights to Kyoto University's induced pluripotent stem cell patent portfolio.

iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.

The French firm licensed non-exclusive rights to certain patents covering research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan.

Cellular Dynamics and iPS Academia Japan announced a non-exclusive licensing agreement giving CDI access to an induced pluripotent stem cell portfolio based on research done by Kyoto University researcher Shinya Yamanaka.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.